Jiří Mayer

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

Elias Jabbour, Hagop M. Kantarjian, Giuseppe Saglio et al. · Blood · 2013 · 391 citations · Full text

Medicine, Hematology, Oncology +8

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

Marek Trněný, Thierry Lamy, Jan Walewski et al. · The Lancet Oncology · 2016 · 156 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

Uwe Platzbecker, Argiris Symeonidis, Esther Natalie Olíva et al. · Leukemia · 2017 · 130 citations · Full text

Medicine, Hematology, Pharmacology +13

The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration

Markéta Kaucká, Karla Plevová, Šárka Pavlová et al. · Cancer Research · 2013 · 105 citations

Life Sciences, Cancer Biology, Oncology +12

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker et al. · Leukemia · 2020 · 92 citations · Full text

Life Sciences, Hematology, Oncology +16